Valuation : Implantica AG

Market Cap 1.54B 1.78B 1.46B 1.32B 2.47B 170B 2.49B 17.29B 6.65B 86.71B 6.7B 6.55B 274B P/E 2026 *
-18.2x
P/E 2027 * -14.7x
Enterprise Value 1.51B 1.75B 1.43B 1.3B 2.43B 167B 2.44B 16.97B 6.53B 85.13B 6.58B 6.43B 269B EV / Sales 2026 *
439x
EV / Sales 2027 * 168x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -

Last Transcript : Implantica AG

1 day-1.45%
1 week+2.69%
Current month+1.33%
1 month+5.17%
3 months+7.77%
6 months+46.63%
Current year+21.76%
1 week 56.4
Extreme 56.4
64.1
1 month 50.8
Extreme 50.8
80.3
Current year 38
Extreme 38
80.3
1 year 38
Extreme 38
80.3
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
109.2
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 2014-12-31
Director of Finance/CFO 48 2019-12-31
Corporate Officer/Principal 69 -
Director TitleAgeSince
Chairman 67 2019-12-31
Director/Board Member 62 2019-12-31
Director/Board Member 71 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
3/31/26 Buy

Chairman

28,135 0.0484%
9/24/25 Sell

Chief Financial Officer

16,700 0.0287%
9/24/25 Sell

Chief Financial Officer

17,100 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%+2.69%-4.39%+133.27% 1.82B
-0.02%-1.06%+16.82%+8.45% 12.52B
-0.59%-4.01%+11.25%+26.12% 6.65B
+0.27%-5.62% - - 6.31B
-1.39%-11.59%+18.43%+8.48% 5.57B
+1.23%-0.49%-20.59%+42.68% 4.98B
-0.24%-1.21%-36.02%-22.57% 3.77B
+1.04%-12.07%+27.03%-22.57% 1.79B
-1.07%-2.99%+40.67%-20.59% 1.59B
-5.68%-4.59%-12.08%+16.34% 1.41B
Average -0.68%-3.10%+4.57%+18.85% 4.64B
Weighted average by Cap. -0.23%-3.25%+5.92%+16.11%

Financials

2026 *2027 *
Net sales 3.43M 3.99M 3.25M 2.95M 5.53M 381M 5.56M 38.62M 14.85M 194M 14.97M 14.64M 612M 9.14M 10.61M 8.66M 7.85M 14.72M 1.01B 14.8M 103M 39.55M 516M 39.86M 38.99M 1.63B
Net income -20.78M -24.11M -19.67M -17.83M -33.45M -2.3B -33.62M -234M -89.85M -1.17B -90.56M -88.58M -3.7B -25.61M -29.72M -24.25M -21.98M -41.23M -2.84B -41.44M -288M -111M -1.44B -112M -109M -4.56B
Net Debt -28.02M -32.53M -26.54M -24.05M -45.12M -3.11B -45.35M -315M -121M -1.58B -122M -119M -5B -1.71M -1.98M -1.62M -1.47M -2.75M -189M -2.76M -19.2M -7.38M -96.3M -7.44M -7.28M -304M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
26-09-11 SEK 61.00 -1.45% 159,300
26-09-10 SEK 61.90 +3.51% 289,331
26-09-09 SEK 59.80 +2.75% 298,243
26-09-08 SEK 58.20 +1.93% 57,703
26-09-07 SEK 57.10 -1.89% 30,246
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.424EUR
Average target price
8.141EUR
Spread / Average Target
+50.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!